Dupilumab treatment for atopic dermatitis associated with reduced risk of alopecia areata: A multicenter cohort study

Authors

• Jasmine Levine, Icahn School of Medicine at Mount Sinai, New York, NY
• Alice Tang, Icahn School of Medicine at Mount Sinai, New York, NY
• Ross O'Hagan, Icahn School of Medicine at Mount Sinai, New York, NY
• Lillian Mo, Icahn School of Medicine at Mount Sinai, New York, NY
• Rahib K. Islam, LSU Health Sciences Center - New OrleansFollow
• Christopher J. Thang, University of Texas Medical Branch, Galveston, TX
• Nicholas Gulati, Icahn School of Medicine at Mount Sinai, New York, NY
• Jordan Talia, Icahn School of Medicine at Mount Sinai, New York, NY
• Emma Guttman-Yassky, Icahn School of Medicine at Mount Sinai, New York, NY
• Benjamin Ungar, Icahn School of Medicine at Mount Sinai, New York, NY

Document Type

Article

Publication Date

3-23-2026

Publication Title

The Journal of Allergy and Clinical Immunology: In Practice

First Page

1

Last Page

9

PubMed ID

41881104

Rights

© 2026 American Academy of Allergy, Asthma & Immunology

Recommended Citation

Levine, Jasmine; Tang, Alice; O'Hagan, Ross; Mo, Lillian; Islam, Rahib K.; Thang, Christopher J.; Gulati, Nicholas; Talia, Jordan; Guttman-Yassky, Emma; and Ungar, Benjamin, "Dupilumab treatment for atopic dermatitis associated with reduced risk of alopecia areata: A multicenter cohort study" (2026). School of Medicine Faculty Publications. 4659.
https://digitalscholar.lsuhsc.edu/som_facpubs/4659
10.1016/j.jaip.2026.03.015